NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
Back to search
Official data from USPTO
SCOLIOSIS REALIGNMENT THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SCOLIOSIS REALIGNMENT THERAPY
ST13
US500000098335124Class
44
Filing
98335124
Registration
7656070
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/14/2025
Trademark type
Word
Nice classes
44
Filing date
12/29/2023
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
01/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
10/08/2023
First use in commerce
10/09/2023
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA, US
Examiner
CONNERS,LAUREN G
Law office
O30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NSite, Inc.
Representatives
Trevor A. Caudle, Esq. Trevor Caudle Law Practice, PC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Physical therapy servicesproviding exercise therapy for individuals with scoliosis
Publications
History of USPTO decisions and trademark events.
26 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/14/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/21/2024
GNRT
NON-FINAL ACTION E-MAILED
11/21/2024
CNRT
NON-FINAL ACTION WRITTEN
11/21/2024
IUAA
USE AMENDMENT ACCEPTED
11/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/01/2024
ALIE
ASSIGNED TO LIE
11/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/07/2024
IUAF
USE AMENDMENT FILED
08/07/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2024
GNRT
NON-FINAL ACTION E-MAILED
08/01/2024
CNRT
NON-FINAL ACTION WRITTEN
08/01/2024
DOCK
ASSIGNED TO EXAMINER
07/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2024
NWAP
NEW APPLICATION ENTERED
12/29/2023
Continuous trademark protection
Get notified about every new filing that threatens SCOLIOSIS REALIGNMENT THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.